Ethicon, Inc.
ethicon.comTotal trials
66
Active
5
Phase 3
16
Total enrollment
20,201
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Hemorrhage8
- Stress Urinary Incontinence6
- Pelvic Organ Prolapse5
- Soft Tissue Bleeding4
- Hemostasis4
- Menorrhagia3
- Uterine Fibroids3
- Non-Small Cell Lung Cancer3
Frequently asked questions about Ethicon, Inc.
- How many clinical trials does Ethicon, Inc. have on ClinicalTrials.gov?
- Ethicon, Inc. is listed as the lead sponsor on 66 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ethicon, Inc.'s trials are in Phase 3?
- 16 of Ethicon, Inc.'s trials are in Phase 3.
- What therapeutic areas does Ethicon, Inc. focus on?
- Ethicon, Inc.'s most-studied conditions on ClinicalTrials.gov are Hemorrhage, Stress Urinary Incontinence, Pelvic Organ Prolapse, Soft Tissue Bleeding, Hemostasis.